Nutrien stock is trading -11.4% below its average target price of $75.27 after dropping -3.2% during today's afternoon session. Analysts are giving the large-cap company an average rating of buy and target prices ranging from $49.0 to $92.0 per share.
The stock has a short ratio of 2.14. At 0.03%, the company's rate of insider ownership does not indicate that management is heavily invested in the corporation.
Institutions Invested in Nutrien
Date Reported | Holder | Percentage | Shares | Value |
---|---|---|---|---|
2023-03-31 | Royal Bank of Canada | 5% | 26,039,212 | $1,736,555,111 |
2023-03-31 | Price (T.Rowe) Associates Inc | 5% | 22,758,328 | $1,517,752,949 |
2023-03-31 | Bank of America Corporation | 4% | 19,638,296 | $1,309,678,008 |
2023-03-31 | Vanguard Group Inc | 4% | 18,095,147 | $1,206,765,397 |
2023-03-31 | Deutsche Bank Aktiengesellschaft | 3% | 15,152,334 | $1,010,509,191 |
2022-12-31 | Bank of Montreal/Can/ | 2% | 12,175,831 | $812,006,199 |
2023-03-31 | Dodge & Cox Inc | 2% | 11,533,359 | $769,159,739 |
2023-03-31 | Mackenzie Financial Corporation | 2% | 11,476,758 | $765,385,019 |
2023-03-31 | Capital International Investors | 2% | 10,264,803 | $684,559,737 |
2023-03-31 | FIL LTD | 2% | 9,957,574 | $664,070,634 |